Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial
Clinical trial NCT04872413 · COMPLETED
Trial details
- NCT number
- NCT04872413
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2025-02-21
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.